144 related articles for article (PubMed ID: 1300350)
1. Efficacy of praziquantel treatment of schistosomiasis in a non-endemic country: a follow-up of parasitological, clinical and immunological parameters.
Giboda M; Loudová J; Shonová O; Boucková E; Horácek J; Numrich P; Ruppel A; Vítovec J; Lukes S; Noll P
J Hyg Epidemiol Microbiol Immunol; 1992; 36(4):346-55. PubMed ID: 1300350
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of praziquantel as an antihelmintic agent in the treatment of bilharziasis].
Doehring E; Ehrich JH
Monatsschr Kinderheilkd; 1986 May; 134(5):282-4. PubMed ID: 3088435
[TBL] [Abstract][Full Text] [Related]
4. [Determination of parasite-specific antibodies during human schistosomiasis--diagnostic relevance].
Sauer H; Leykun J; Schubert S
Angew Parasitol; 1992 Aug; 33(3):151-9. PubMed ID: 1416221
[TBL] [Abstract][Full Text] [Related]
5. Enzyme linked immunosorbent assay for the evaluation of praziquantel therapy in different groups of bilharzial patients.
Ismail MM; Ata AA; el-Raziky EH; el-Ridi AM; Attia MM; el-Gamal RL; el-Khashab M
J Egypt Soc Parasitol; 1986 Jun; 16(1):269-76. PubMed ID: 3088143
[No Abstract] [Full Text] [Related]
6. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
Taylor P; Murare HM; Manomano K
J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
[TBL] [Abstract][Full Text] [Related]
7. [Surprising findings in the colon 15 years after a holiday in Africa].
Köppen S; Kellner U; Huchzermeyer H
Dtsch Med Wochenschr; 2005 May; 130(18):1139-42. PubMed ID: 15856396
[TBL] [Abstract][Full Text] [Related]
8. The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium.
Mutapi F; Mduluza T; Ndhlovu PD
Mem Inst Oswaldo Cruz; 2002; 97 Suppl 1():173-80. PubMed ID: 12426616
[TBL] [Abstract][Full Text] [Related]
9. A recombinant protein from Schistosoma mansoni useful for the detection of S. mansoni and Schistosoma haematobium antibodies.
Hancock K; Mohamed YB; Haichou X; Noh J; Dotson EM; Tsang VC
J Parasitol; 1997 Aug; 83(4):612-8. PubMed ID: 9267400
[TBL] [Abstract][Full Text] [Related]
10. Immunological analysis of cloned Schistosoma mansoni antigens Sm31 and Sm32 with sera of schistosomiasis patients.
Klinkert MQ; Bommert K; Moser D; Felleisen R; Link G; Doumbo O; Beck E
Trop Med Parasitol; 1991 Dec; 42(4):319-24. PubMed ID: 1796225
[TBL] [Abstract][Full Text] [Related]
11. [Schistosomiasis at Marselisborg hospital 1981-1990].
Tarp BD; Andersen PL
Ugeskr Laeger; 1996 Feb; 158(7):911-4. PubMed ID: 8638328
[TBL] [Abstract][Full Text] [Related]
12. Population level changes in schistosome-specific antibody levels following chemotherapy.
Fukushige M; Mutapi F; Woolhouse MEJ
Parasite Immunol; 2019 Jan; 41(1):e12604. PubMed ID: 30467873
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cure in schistosomiasis patients after chemotherapy with praziquantel by quantitation of circulating anodic antigen (CAA) in urine.
van Lieshout L; de Jonge N; Bassily S; Mansour MM; Deelder AM
Am J Trop Med Hyg; 1991 Mar; 44(3):323-8. PubMed ID: 1903605
[TBL] [Abstract][Full Text] [Related]
15. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens.
Mutapi F; Burchmore R; Mduluza T; Foucher A; Harcus Y; Nicoll G; Midzi N; Turner CM; Maizels RM
J Infect Dis; 2005 Sep; 192(6):1108-18. PubMed ID: 16107967
[TBL] [Abstract][Full Text] [Related]
16. [A case report: Bilharzial schistosomiasis in the urinary bladder presented with gross hematuria].
Tsuboi T; Matsumoto K; Irie A; Hirayama T; Tsumura H; Hirai S; Satoh T; Iwamura M; Baba S; Takayama Y
Hinyokika Kiyo; 2006 Apr; 52(4):281-3. PubMed ID: 16686356
[TBL] [Abstract][Full Text] [Related]
17. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the efficacy of different doses of praziquantel by quantification of circulating antigens in serum and urine of schistosomiasis patients.
van Lieshout L; de Jonge N; el-Masry N; Mansour MM; Bassily S; Krijger FW; Deelder AM
Parasitology; 1994 Jun; 108 ( Pt 5)():519-26. PubMed ID: 8052507
[TBL] [Abstract][Full Text] [Related]
19. Serodiagnosis of Schistosoma mansoni infections in an endemic area of Burkina Faso: performance of several immunological tests with different parasite antigens.
Sorgho H; Bahgat M; Poda JN; Song W; Kirsten C; Doenhoff MJ; Zongo I; Ouédraogo JB; Ruppel A
Acta Trop; 2005 Feb; 93(2):169-80. PubMed ID: 15652331
[TBL] [Abstract][Full Text] [Related]
20. Mixed Schistosoma haematobium and S. mansoni infection: effect of different treatments on the serum level of circulating anodic antigen (CAA).
de Jonge N; Schommer G; Feldmeier H; Krijger FW; Dafalla AA; Bienzle U; Deelder AM
Acta Trop; 1990 Oct; 48(1):25-35. PubMed ID: 1980801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
